Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:12AM EDT. Market open.
| Previous close | 6.09 |
| Open | 6.10 |
| Bid | 5.99 x 3200 |
| Ask | 6.00 x 1100 |
| Day's range | 5.97 - 6.17 |
| 52-week range | 2.50 - 9.49 |
| Volume | |
| Avg. volume | 864,374 |
| Market cap | 748.175M |
| Beta (5Y monthly) | 2.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Seres Therapeutics (MCRB) Moves 10.9% Higher: Will This Strength Last?
Seres Therapeutics (MCRB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Zacks
Seres Therapeutics (MCRB) Reports Q4 Loss, Misses Revenue Estimates
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -31.71% and 89.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Seres Therapeutics' (NASDAQ:MCRB) investors will be pleased with their respectable 70% return over the last three years
The last three months have been tough on Seres Therapeutics, Inc. ( NASDAQ:MCRB ) shareholders, who have seen the share...
© 2023 Yahoo. All rights reserved.
